Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Assets Average (2019 - 2025)

Precision Biosciences (DTIL) has disclosed Assets Average for 7 consecutive years, with $124.0 million as the latest value for Q4 2025.

  • Quarterly Assets Average fell 14.4% to $124.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $124.0 million through Dec 2025, down 14.4% year-over-year, with the annual reading at $145.4 million for FY2025, 1.81% down from the prior year.
  • Assets Average for Q4 2025 was $124.0 million at Precision Biosciences, up from $101.2 million in the prior quarter.
  • The five-year high for Assets Average was $284.4 million in Q3 2022, with the low at $101.2 million in Q3 2025.
  • Average Assets Average over 5 years is $187.5 million, with a median of $184.2 million recorded in 2023.
  • The sharpest move saw Assets Average skyrocketed 37.59% in 2021, then plummeted 39.17% in 2023.
  • Over 5 years, Assets Average stood at $219.3 million in 2021, then increased by 16.23% to $255.0 million in 2022, then tumbled by 36.43% to $162.1 million in 2023, then fell by 10.64% to $144.8 million in 2024, then decreased by 14.4% to $124.0 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $124.0 million, $101.2 million, and $116.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.